OBJECTIVE	To determine whether noneosinophilic , steroid-naive asthmatic subjects show an improvement in asthma control , asthma symptoms and spirometry after four weeks of treatment with ICS , and whether they further benefit from the addition of a long-acting beta-2 agonists to ICS .\